A Trial to Evaluate the Efficacy and Safety of PQ912 in Patients With Early AD

Clinical trial NCT03919162 · TERMINATED

Trial details

NCT number: NCT03919162
Sponsor: Vivoryon Therapeutics N.V.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2021-11-15
Primary completion: 2024-07-12
Enrollment: 112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.